Discover the Latest AI News: Nvidia’s 3 Chips for China, Bad Bunny’s Critique, and More!
Today, November 9, the artificial intelligence world was filled with noise and controversy due to a new technology. Firstly, it has been reported that Nvidia plans to release three AI chips specifically for China. This announcement comes shortly after the US government imposed restrictions on the trade of advanced semiconductors with China, resulting in Nvidia being unable to sell its high-end A800 and H800 series chipsets to China. Additionally, rapper Bad Bunny took to his WhatsApp Channel to urge fans to refrain from listening to a viral song on TikTok that was created using AI to imitate his voice. These are just a few highlights from today’s AI news roundup, so let’s delve deeper into the details.
Nvidia releases three AI chips for China
According to a Bloomberg report, Nvidia is releasing three new AI chips to China in response to recent U.S. restrictions on semiconductor exports to China. These chips are based on the design of Nvidia’s flagship H100 product, and Chinese companies are expected to receive them soon. The US had previously placed restrictions on China’s AI accelerators due to national security concerns. The move comes after Nvidia faced a drop in inventories as the US government tried to limit sales of advanced chips to China, affecting its product development and ability to supply customers.
Bad Bunny makes AI sound
Bad Bunny has expressed strong disapproval of a viral TikTok song that uses artificial intelligence to mimic his voice, a Billboard report said. In a message sent to fans on his WhatsApp channel, the artist expressed his displeasure and demanded that anyone enjoying the AI-generated song leave his group. He emphasized that he wants fans to focus on his new album, “Nadie Sabe Lo Que Va a Pasar Manana.” The specific AI-generated song that upset Bad Bunny is unclear, as there are several such songs currently circulating on TikTok.
He said on WhatsApp (translated by Google): “There are people I get along with and people I don’t… there are people I connect with and I don’t…. If you happen to enjoy that trivial TikTok song, please leave this group immediately . You don’t deserve my friendship.”
DreamWorks founder: AI can cut costs of animated films by 90%
Artificial intelligence will dramatically reduce the cost of creating successful animated films, believes DreamWorks founder Jeffrey Katzenberg. He said during a panel discussion at the Bloomberg New Economy Forum on Thursday, according to its report: “I don’t know of any industry that’s affected more than any aspect of media, entertainment and creation. In the good old days, you might need 500 artists and years to make a world-class animated film. I don’t think it will take 10 percent of that in three years.”
Katzenberg, known for his career as a production executive at the Walt Disney Co. film studio and co-founder of DreamWorks with filmmaker Steven Spielberg and Hollywood executive David Geffen, predicts that the introduction of artificial intelligence will accelerate the digital transformation of the entertainment industry. by a factor of 10.
The financial industry opposes the SEC’s proposed artificial intelligence rules for advising clients
According to a Financial Times report, brokers, hedge funds and investment advisers are strongly opposed to the US Securities and Exchange Commission’s (SEC) efforts to regulate the use of artificial intelligence in financial advice. The SEC’s proposed rules in July aim to force banks and fund managers to address technology-related conflicts of interest when advising clients. Many industry stakeholders have criticized the broad scope of these rules and characterized the SEC’s approach as arbitrary and capricious, with comments continuing beyond the Oct. 10 deadline.
Chelsea Clinton’s venture capital firm invests in an artificial intelligence startup
According to a Fox Business report, Chelsea Clinton’s venture capital firm Metrodora Ventures is backing BioPhy, a health technology startup that uses artificial intelligence to accelerate drug development and improve the prediction of clinical trial success. BioPhy is slated to launch with $4 million in upfront funding, primarily from Metrodora. The company’s AI operating system has already shown promising results. Led by CEO Dave Lawtshaw II, BioPhy was founded in 2019, and Lawtshaw previously worked at Johnson & Johnson, where he played a key role in deploying artificial intelligence at various stages of drug development from inception to commercial approval.
